Regårdh, Carl Gunnar
AstraZeneca,
United Kingdom
2025 Rank: 225066
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
General Clinical Medicine
Rank in SubField 1: 2190 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 225066 | 254809 |
| Total Cites | 3341 | 3508 |
| H-index | 31 | 32 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 68 | 68 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 532 | 536 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 1216 | 1266 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2603 | 2689 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
4.76%
|
|
Regårdh, Carl Gunnar
AstraZeneca,
Germany
2023 Rank: 213765
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 2162 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 213765 | 239258 |
| Total Cites | 3117 | 3284 |
| H-index | 30 | 32 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 60 | 60 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 491 | 495 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 1109 | 1159 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2426 | 2512 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
5.09%
|
|
Regårdh, Carl Gunnar
AstraZeneca,
Germany
2022 Rank: 204807
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 2091 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 204807 | 229132 |
| Total Cites | 2973 | 3138 |
| H-index | 29 | 31 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 60 | 60 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 468 | 472 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 1057 | 1107 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2317 | 2402 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
5.26%
|
|
Regårdh, Carl Gunnar
AstraZeneca,
Germany
2021 Rank: 195590
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 2024 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 195590 | 221702 |
| Total Cites | 2916 | 3080 |
| H-index | 29 | 30 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 59 | 59 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 458 | 462 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 1041 | 1091 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2276 | 2361 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
5.32%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.